Nuclear Medicine: Page 128

Global isotope market could reach $7B by 2020

By AuntMinnie.com staff writers

Widespread use of radiopharmaceutical isotopes with diagnostic equipment such as PET and SPECT systems could buoy the global nuclear medicine/radiopharmaceutical market to $7 billion by the end of the decade.

July 7, 2015

Navidea touts Manocept clinical trial

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals and its Macrophage Therapeutics subsidiary are touting the results of their Manocept clinical trial for Kaposi's sarcoma.

July 1, 2015

AAA signs Fuji as distributor in Japan

By AuntMinnie.com staff writers

French molecular imaging firm Advanced Accelerator Applications (AAA) has signed a distribution deal for its Lutathera radiopharmaceutical with Fujifilm RI Pharma in Japan.

June 30, 2015

Lantheus sets IPO stock price

By AuntMinnie.com staff writers

Lantheus Medical Imaging's parent company, Lantheus Holdings, has set the price for its stock at $6 per share for its initial public offering (IPO) on the Nasdaq stock exchange.

June 24, 2015

AAA nets $29M for new products

By AuntMinnie.com staff writers

French molecular imaging firm Advanced Accelerator Applications (AAA) has garnered $28.7 million (23 million euros) in financing from U.S.-based investors.

June 24, 2015

Proposal would dissolve ABNM, fold functions into ABR

By Wayne Forrest

In the face of an increasingly difficult job market for nuclear medicine physicians, a proposal has been floated to dissolve the American Board of Nuclear Medicine (ABNM) and fold its functions into the American Board of Radiology (ABR). The combined organization would oversee a new, broader certification for imaging specialists.

June 24, 2015

Florbetaben-PET finds more beta-amyloid plaques

By Wayne Forrest

New research indicates that PET imaging with the radiotracer florbetaben can detect a form of beta-amyloid plaque that develops early in the brain. The findings could possibly lead to the earlier detection of Alzheimer's disease, as well as new clinical indications for florbetaben.

June 21, 2015

Lantheus schedules IPO for June 25

By AuntMinnie.com staff writers

Lantheus Medical Imaging's parent company, Lantheus Holdings, is set to launch its initial public offering (IPO) of stock on June 25.

June 18, 2015

PETNet to offer PET prostate tracer

By AuntMinnie.com staff writers

Siemens Healthcare said its PETNet Solutions subsidiary will begin offering a prostate cancer radiotracer for use in clinical trials in the New York City area.

June 18, 2015

Shine, Argonne demo Mo-99 process

By AuntMinnie.com staff writers

Shine Medical Technologies and Argonne National Laboratory have successfully demonstrated the production, separation, and purification of molybdenum-99 (Mo-99) from a liquid target provided by Shine.

June 14, 2015

FDA classifies Cellectar agent as combination product

By AuntMinnie.com staff writers

Cellectar Biosciences said the U.S. Food and Drug Administration has determined that its CLR1502 tumor margin illumination agent will be evaluated as a combination product and assigned to the Center for Devices and Radiological Health.

June 11, 2015

Annals: Few differences in CCTA vs. SPECT MPI

By Eric Barnes

A study comparing coronary CT angiography (CCTA) with SPECT myocardial perfusion imaging (MPI) in chest pain patients found that CT's radiation dose was lower and that it yielded fewer unpleasant experiences among patients, according to results published in the Annals of Internal Medicine.

June 10, 2015

Previous Page

Page 128 of 440

Next Page